How might a Patent Term Adjustment affect an Obviousness-type Double Patenting analysis? | Fieldfisher
![Patent Owner Can Select Patent Term to Extend for FDA Delay, says Federal Circuit — Grüneberg and Myers - Intellectual Property Law Patent Owner Can Select Patent Term to Extend for FDA Delay, says Federal Circuit — Grüneberg and Myers - Intellectual Property Law](https://images.squarespace-cdn.com/content/v1/59a3244d6b8f5be6470171ca/1544411553028-K7KZ8BTTYYG38IAOFZ2T/Novartis+v+Ezra+timeline.png)
Patent Owner Can Select Patent Term to Extend for FDA Delay, says Federal Circuit — Grüneberg and Myers - Intellectual Property Law
![1895-A Continuation, Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States 1895-A Continuation, Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States](https://www.uspto.gov/web/offices/pac/mpep/graphics/1895_01-1.png)
1895-A Continuation, Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States
Kaustubh Nadkarni | Lawyer on Instagram: "The term for a continuation-in-part patent does not mirror that of its parent application. Any claims that contain the newly added matter are given 20 years
![Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm](https://www.finnegan.com/a/web/247329/2G4HEh/pf_1.png)